Cite Filings / STLN / 0001628280-22-013933

Feed Companies Filings Check

Sign in

424B3

Prospectus

Starling Oncology, Inc. Filed 2022-05-12 Acc 0001628280-22-013933

Documents 1

424B3 Prospectus , toi-424xsharerepurchase202.htm

Around this filing

2022-06-03 424B3 Prospectus
2022-05-13 4 10% owner sold 1,600,000 shares at $6.00 ($9,600,000)
2022-05-12 424B3 Prospectus
2022-05-12 8-K Other events
2022-05-12 S-8 Securities Offered to Employees in Benefit Plans
2022-05-11 8-K Results of operations · Regulation FD disclosure
2022-05-11 424B3 Prospectus

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading toi-424xsharerepurchase202.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…